Borosil Scientific Ltd Stock Hits 52-Week Low at Rs.109

Stock Performance and Market Context

On 20 Jan 2026, Borosil Scientific Ltd’s stock price touched an intraday low of Rs.109, representing both a new 52-week and all-time low. This decline came alongside a day’s fall of -2.46%, underperforming the Industrial Products sector by -0.62%. The stock has been on a downward trajectory for two consecutive sessions, losing -6.12% over this period.

Technical indicators show the stock trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling sustained bearish momentum. This contrasts with the broader market, where the Sensex, despite a negative close at 82,597.03 (-0.78%), remains within 4.31% of its 52-week high of 86,159.02. However, the Sensex itself has been on a three-week losing streak, down -3.69% in that span.

Over the past year, Borosil Scientific Ltd’s stock has declined by -34.38%, markedly underperforming the Sensex’s positive return of 7.16%. The stock’s 52-week high was Rs.190.45, highlighting the extent of the recent correction.

Financial Metrics and Profitability Analysis

Borosil Scientific Ltd’s financial performance has shown signs of strain over recent periods. The company’s return on equity (ROE) stands at a modest 4.53%, indicating limited profitability relative to shareholders’ funds. This low ROE reflects subdued efficiency in generating returns from equity capital.

Long-term growth has also been modest, with net sales increasing at an annualised rate of 9.80% over the past five years, while operating profit growth has been even more restrained at 2.86% annually. These figures suggest challenges in scaling profitability despite revenue growth.

Recent quarterly results further underline these concerns. For the quarter ending September 2025, profit before tax (PBT) excluding other income was Rs.2.98 crores, a sharp decline of -55.8% compared to the previous four-quarter average. The nine-month profit after tax (PAT) stood at Rs.14.01 crores, reflecting a contraction of -39.40%. Notably, non-operating income accounted for 41.91% of PBT, highlighting a significant reliance on income sources outside core operations.

Shareholding and Market Perception

Despite Borosil Scientific Ltd’s size, domestic mutual funds hold a minimal stake of just 0.04%. Given their capacity for detailed research and due diligence, this limited exposure may indicate cautious sentiment towards the stock’s valuation or business fundamentals.

The stock’s Mojo Score currently stands at 31.0, with a Mojo Grade of Sell, upgraded from a previous Strong Sell on 19 Jan 2026. The company’s market capitalisation grade is rated at 3, reflecting its mid-tier size within the Industrial Products sector.

Over the last three years, Borosil Scientific Ltd has underperformed the BSE500 index across multiple timeframes, including the last three months and one year, reinforcing a pattern of below-par returns relative to broader market benchmarks.

Debt and Valuation Considerations

On a positive note, the company maintains a low average debt-to-equity ratio of zero, indicating a debt-free capital structure. This conservative financial leverage reduces risk related to interest obligations and balance sheet strain.

Valuation metrics show a price-to-book value ratio of 2.4, which aligns with the company’s modest ROE of 4.5%, suggesting a fair valuation relative to its equity base. Despite the stock’s price decline, reported profits have risen by 11% over the past year, indicating some resilience in earnings despite market pressures.

Summary of Recent Trends

The stock’s recent decline to Rs.109 marks a significant technical milestone, reflecting sustained downward pressure amid a challenging operating environment. The two-day consecutive fall of -6.12% and underperformance relative to sector and market indices underscore the stock’s current weakness.

While the company’s debt-free status and fair valuation metrics provide some stability, the low ROE, subdued profit growth, and reliance on non-operating income remain areas of concern. The limited mutual fund holding further suggests restrained institutional confidence.

Overall, Borosil Scientific Ltd’s stock performance and financial indicators point to a period of subdued momentum, with the 52-week low serving as a key reference point for market participants analysing the company’s recent trajectory.

Unlock special upgrade rates for a limited period. Start Saving Now →